Moreover, GAL3ST1 is an HIF1 target gene, and its expression is induced upon loss of von Hippel-Lindau (VHL) tumor suppressor, leading to accumulation of its enzymatic product sulfatide. The gene discussed is HIF1A; the disease is neoplasm.